4//SEC Filing
SARGEN GREGORY 4
Accession 0001683168-23-008944
CIK 0000704562other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 7:33 PM ET
Size
9.8 KB
Accession
0001683168-23-008944
Insider Transaction Report
Form 4
SARGEN GREGORY
Director
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2023-12-14+9,612→ 9,612 total - Exercise/Conversion
Restricted Stock Units
2023-12-14−9,612→ 0 total→ Common Stock (9,612 underlying) - Award
Restricted Stock Units
2023-12-14+26,756→ 26,756 total→ Common Stock (26,756 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
- [F2]RSUs granted to the reporting person on December 14, 2022 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2023.
- [F3]Annual equity award grant pursuant to the Issuer's non-employee director compensation program.
- [F4]RSUs granted to the reporting person on December 14, 2023 shall fully vest on December 14, 2024, subject to the reporting person's continuous service to the Issuer on such vesting date.
Documents
Issuer
Avid Bioservices, Inc.
CIK 0000704562
Entity typeother
Related Parties
1- filerCIK 0001227835
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 7:33 PM ET
- Size
- 9.8 KB